ライフサイエンスコーパス: hematopoietic progenitor

1 t least 10(1)(3)-fold) expansion of immature hematopoietic progenitors.

2 ecreased expression of multiple Hox genes in hematopoietic progenitors.

3 and disrupts cis-regulatory architecture of hematopoietic progenitors.

4 s proliferation of embryonic fibroblasts and hematopoietic progenitors.

5 erate with GATA1s in transformation of fetal hematopoietic progenitors.

6 e expression of ETO and RUNX1 genes in human hematopoietic progenitors.

7 ythroid-specific genes within populations of hematopoietic progenitors.

8 tem cells (HSCs) and other lineage-committed hematopoietic progenitors.

9 the in vitro differentiation of iPSC toward hematopoietic progenitors.

10 udied erythropoiesis using knockout mice and hematopoietic progenitors.

11 lineages and colony-forming unit assays for hematopoietic progenitors.

12 y in the absence of PRC1, to fully transform hematopoietic progenitors.

13 nervous system (SNS) regulates neuronal and hematopoietic progenitors.

14 alternative for studying telomere crisis in hematopoietic progenitors.

15 ty of mast cells to differentiate from their hematopoietic progenitors.

16 odor environments fail to sustain a pool of hematopoietic progenitors.

17 ) and mouse bone marrow cells, which contain hematopoietic progenitors.

18 ile promoting the self-renewal of very early hematopoietic progenitors.

19 definitive repopulation status on primitive hematopoietic progenitors.

20 ent apoptotic effectors targeting autologous hematopoietic progenitors.

21 olonies, indicating that these cells are not hematopoietic progenitors.

22 HES1) expression and generation of committed hematopoietic progenitors.

23 eukemogenic in vivo when expressed in normal hematopoietic progenitors.

24 induction of myeloid fate from hESC-derived hematopoietic progenitors.

25 factor (SCF) is expressed on mast cells and hematopoietic progenitors.

26 ytokine signaling to HSCs and more committed hematopoietic progenitors.

27 nome to direct fate lineage determination of hematopoietic progenitors.

28 ommitment were mediated by beta3 integrin on hematopoietic progenitors.

29 hat regulate the differentiation capacity of hematopoietic progenitors.

30 osine kinase that leads to transformation of hematopoietic progenitors.

31 evelop from MPP2, a myeloid-biased subset of hematopoietic progenitors.

32 filtration of the bone marrow by transformed hematopoietic progenitors.

33 e enriched in NKT progenitors, like in other hematopoietic progenitors.

34 es the ex vivo characterization of zebrafish hematopoietic progenitors.

35 HPs transcriptionally resemble native Kit(+) hematopoietic progenitors.

36 oform of SON enhances replating potential of hematopoietic progenitors.

37 also revealed a prethymic role for BCL11B in hematopoietic progenitors.

38 -BP1) and 4E-BP2 as compared with most other hematopoietic progenitors.

39 promote monocyte/macrophage development from hematopoietic progenitors, a process critical in trigger

40 spheres can significantly expand multipotent hematopoietic progenitors able to engraft immunodeficien

41 B cells into IFrag(-/-) mice protects early hematopoietic progenitor activity during systemic respon

42 mice resulted in an accelerated recovery of hematopoietic progenitor activity in bone marrow and a m

43 iver exhibited severe deficiency in HSCs and hematopoietic progenitors, along with elevated reactive

44 iota is known to influence the generation of hematopoietic progenitors, although the pathways underly

45 esized that the arterial wall is a source of hematopoietic progenitor and stem cells in postnatal lif

46 scontinuous sinusoids also allow circulating hematopoietic progenitor and stem cells to populate the

47 potent stem (iPS) cell reprogramming of aged hematopoietic progenitors and allowed the resulting aged

48 Hematopoietic progenitors and DC precursors were signifi

49 hat express a hyperactive mutant of Stat5 in hematopoietic progenitors and derived lineages in a liga

50 rophages are derived from primitive yolk-sac hematopoietic progenitors and exhibit hallmarks of M2 ac

51 ia (MLL) trigger aberrant gene expression in hematopoietic progenitors and give rise to an aggressive

52 Ddb1 is highly expressed in multipotent hematopoietic progenitors and its deletion leads to abro

53 L-RARA mice, which express PML-RARA in early hematopoietic progenitors and myeloid precursors, with o

54 tablished that during embryonic development, hematopoietic progenitors and stem cells are generated f

55 alpha (Peg-IFNalpha 2a) to target JAK2V617F hematopoietic progenitors and stem cells.

56 vites evolutionary parallels with vertebrate hematopoietic progenitors and the independent myeloid sy

57 nt by preserving immune resources, including hematopoietic progenitors and thymic activity, which cou

58 protein synthesis in HSCs, but not in other hematopoietic progenitors, and impaired their reconstitu

59 matopoietic engraftment and clonogenicity of hematopoietic progenitors, and is dependent on secreted

60 ression, enhanced self-renewal, expansion of hematopoietic progenitors, and myeloid differentiation b

61 deletion of Chd1 leads to loss of definitive hematopoietic progenitors, anemia, and lethality by embr

62 We show that Hdac8-deficient hematopoietic progenitors are compromised in colony-form

63 Human hematopoietic progenitors are generally assumed to requi

64 ence with expansion and differentiation into hematopoietic progenitors are incompletely understood.

65 Our results indicate that hematopoietic progenitors are particularly sensitive to

66 Subsets of murine hematopoietic progenitors are privileged whose progeny c

67 Hematopoietic progenitors are regulated in their respect

68 oughout adult life, macrophages derived from hematopoietic progenitors are seeded throughout the body

69 tability; and (3) increasing self-renewal in hematopoietic progenitors, as all of these events are af

70 plerixafor results in rapid mobilization of hematopoietic progenitors, but fails to mobilize 33% of

71 iple subsets of highly purified intermediate hematopoietic progenitors by wild-type HIV both in vitro

72 ony-forming cells belong to the conventional hematopoietic progenitor cell (HPC) compartment.

73 by which that occurs, using an immortalized hematopoietic progenitor cell line, EML-C1, as a model s

74 igratory responses of cocultured stromal and hematopoietic progenitor cell lines, helping explain how

75 factor (VEGF), VEGF receptor, and CD34/CD31 (hematopoietic progenitor cell marker/endothelial cell ma

76 ability in hematopoietic stem cell (HSC) and hematopoietic progenitor cell populations from young and

77 Somatic mutations were tracked to CD34(+) hematopoietic progenitor cell populations, being further

78 ation of ERK in these cells led to rescue of hematopoietic progenitor cell proliferation in vitro and

79 ug sensitivity, and abrogated MPP1-dependent hematopoietic progenitor cell replating in methylcellulo

80 s of thrombotic microangiopathy secondary to hematopoietic progenitor cell transplantation, infection

81 ith significantly increased numbers of HSCs, hematopoietic progenitor cell-1 (HPC-1), HPC-2, and Lin(

82 They, together with hematopoietic progenitor cells (collectively known as HS

83 t3 ligand to conditionally immortalize early hematopoietic progenitor cells (Hoxb8-FL cells).

84 report that inhibition of Notch signaling in hematopoietic progenitor cells (HPC), myeloid-derived su

85 xpression of RUNX1a facilitates emergence of hematopoietic progenitor cells (HPCs) and positively reg

86 Hematopoietic progenitor cells (HPCs) are central to hem

87 oiesis characterized by increased numbers of hematopoietic progenitor cells (HPCs) at the expense of

88 hierarchy among intermediate populations of hematopoietic progenitor cells (HPCs) derived from human

89 fety and effectiveness of mobilizing CD34(+) hematopoietic progenitor cells (HPCs) in adults with bet

90 Hematopoietic progenitor cells (HPCs) in the bone marrow

91 In CD34(+) hematopoietic progenitor cells (HPCs) infected in vitro,

92 d CD34(+)CXCR4(+) cells as well as assayable hematopoietic progenitor cells (HPCs) irrespective of th

93 rus (HCMV) can establish latent infection in hematopoietic progenitor cells (HPCs) or CD14 (+) monocy

94 (HSCs), impaired radioprotective function of hematopoietic progenitor cells (HPCs), and myeloid and e

95 determine the effect of fibrosis on healthy hematopoietic progenitor cells (HPCs), bioartificial mat

96 t5 deletion resulted in a concurrent loss of hematopoietic progenitor cells (HPCs), leading to fatal

97 d lung homing of bone marrow-derived CD34(+) hematopoietic progenitor cells (HPCs), which include eos

98 c stem cells (HSCs) generate highly dividing hematopoietic progenitor cells (HPCs), which produce all

99 n cytomegalovirus (HCMV) resides latently in hematopoietic progenitor cells (HPCs).

100 entiation of hematopoietic stem cells (HSCs)/hematopoietic progenitor cells (HPCs).

101 , we characterized human iPS-derived CD34(+) hematopoietic progenitor cells (HPCs).

102 mportant for the latent infection in CD34(+) hematopoietic progenitor cells (HPCs).

103 tor of CXCR4 expression in human CB HSCs and hematopoietic progenitor cells (HPCs).

104 eting MF hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs).

105 ation of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs).

106 production of large numbers of primary human hematopoietic progenitor cells (HPs) capable of differen

107 transcriptomic profiling of normal human HSC/hematopoietic progenitor cells [HPCs], revealing that se

108 ed for LC differentiation from human CD34(+) hematopoietic progenitor cells and blood monocytes in vi

109 iferation and appropriate differentiation of hematopoietic progenitor cells and in animal hematopoies

110 tein that confers self-renewal capability to hematopoietic progenitor cells and induces acute myeloge

111 ga-dose" of T cell-depleted peripheral blood hematopoietic progenitor cells and no posttransplant pha

112 patient can be induced to differentiate into hematopoietic progenitor cells and then further to eryth

113 ired for latency and reactivation in CD34(+) hematopoietic progenitor cells and virion maturation in

114 The findings indicate that Th2-promoting hematopoietic progenitor cells are rapidly recruited to

115 Hematopoietic progenitor cells are the progeny of hemato

116 wth factor A (Vegf-a)-dependent apoptosis of hematopoietic progenitor cells associated with overprodu

117 opoiesis and changes in pre-mRNA splicing in hematopoietic progenitor cells by whole transcriptome an

118 The abrogation of hematopoietic progenitor cells can be partially rescued

119 Recent studies have found that peripheral hematopoietic progenitor cells contribute to type 2 cyto

120 fies frequencies of growth-factor responsive hematopoietic progenitor cells during steady state and a

121 n attenuated strain of CMV are maintained in hematopoietic progenitor cells during their differentiat

122 reviously shown that HCMV infection of human hematopoietic progenitor cells engrafted in immune defic

123 We next analyzed the fetal hematopoietic progenitor cells for changes in reactive o

124 tropenias and for mobilization of peripheral hematopoietic progenitor cells for stem cell transplanta

125 ultured from peripheral blood or bone marrow hematopoietic progenitor cells from four patients were u

126 ce-activated cell sorting (FACS) of c-kit(+) hematopoietic progenitor cells from mixed bone marrow po

127 BM) chimeras were generated by transplanting hematopoietic progenitor cells from stress-susceptible m

128 creased rDNA promoter methylation in CD34(+) hematopoietic progenitor cells from the majority of MDS

129 These features prevented hematopoietic progenitor cells from transmigrating into

130 creased the proportion of JAK2V617F-positive hematopoietic progenitor cells in 6 PV patients studied.

131 e proportion of phenotypic HSCs and immature hematopoietic progenitor cells in phase G0 of the cell c

132 tly used to stimulate bone marrow release of hematopoietic progenitor cells in preparation for stem c

133 hich a low ROS level is required to maintain hematopoietic progenitor cells in the tissue and to redu

134 for E-selectin binding and for migration of hematopoietic progenitor cells into the bone marrow.

135 CCR9 controls the immigration of multipotent hematopoietic progenitor cells into the thymus to sustai

136 skewing promote oncogenic transformation of hematopoietic progenitor cells into therapy-resistant le

137 We found that RPS19 deficiency in hematopoietic progenitor cells leads to decreased GATA1

138 Using adult hematopoietic progenitor cells our system demonstrated t

139 Murine hematopoietic progenitor cells overexpressing MPP1 acqui

140 lation and the expression of PML-RARalpha in hematopoietic progenitor cells prevented differentiation

141 ients with systemic histiocytoses resides in hematopoietic progenitor cells prior to committed monocy

142 In vitro exposure of human or murine hematopoietic progenitor cells to 10 mum ABA does not in

143 elogenous leukemia (CML) caused normal mouse hematopoietic progenitor cells to divide more readily, a

144 Mechanistically, 1,25(OH)2D3 drives hematopoietic progenitor cells to rapidly upregulate mon

145 Hematopoietic progenitor cells were also significantly i

146 y glycosyltransferases, and decorates marrow hematopoietic progenitor cells with alpha2,6-linked sial

147 f a human cell AML, generated in CD34+ human hematopoietic progenitor cells xenografted into immunoco

148 thma, decreased B-lymphocyte development and hematopoietic progenitor cells, and lymphoid organ hypop

149 ndogenously expressed by a mast cell line or hematopoietic progenitor cells, and specifically blocks

150 n, intermediate reactivity toward monocytes, hematopoietic progenitor cells, and T-cells was observed

151 is detected in hematopoietic stem cells and hematopoietic progenitor cells, and that its expression

152 combined with Peg IFN-alpha 2a can target PV hematopoietic progenitor cells, eliminating the numbers

153 cells, we transduced lineage-depleted murine hematopoietic progenitor cells, observing GFP expression

154 asia, fibrosis, and impaired colonization by hematopoietic progenitor cells, resulting in anemia and

155 of T-lineage specification in human CD34(+) hematopoietic progenitor cells, similar to ICN1 overexpr

156 Conversely, in hematopoietic progenitor cells, the inhibition of miR-9

157 Although both ligands activated Notch in hematopoietic progenitor cells, they had an opposite eff

158 t-like or a replicative infection in CD34(+) hematopoietic progenitor cells, we defined classes of lo

159 ssion and ex vivo differentiation of CD34(+) hematopoietic progenitor cells, we demonstrate that C/EB

160 n functions to promote a latent state within hematopoietic progenitor cells.

161 en human CML were cultured with normal human hematopoietic progenitor cells.

162 ), Ly6C(high) myeloid cells from bone marrow hematopoietic progenitor cells.

163 activated in AML cells compared with normal hematopoietic progenitor cells.

164 n led to gain of replating capacity of mouse hematopoietic progenitor cells.

165 the differentiation process of iPSCs toward hematopoietic progenitor cells.

166 est that these tumors may arise instead from hematopoietic progenitor cells.

167 iminated the total number of JAKV617F(+) MPN hematopoietic progenitor cells.

168 g is critical for the self-renewal of normal hematopoietic progenitor cells.

169 B-cell neoplasm by inducing tumorigenesis in hematopoietic progenitor cells.

170 d STAT5 on LEF-1 expression and functions in hematopoietic progenitor cells.

171 n, as it affects the differentiation of most hematopoietic progenitor cells.

172 ll cycle arrest in HSCs and profound loss of hematopoietic progenitor cells.

173 redundant and kinase-dependent functions in hematopoietic progenitor cells.

174 he levels of ESL-1 were strongly elevated in hematopoietic progenitor cells.

175 h functions as a growth factor for primitive hematopoietic progenitor cells.

176 ells of the myeloid lineage, such as CD34(+) hematopoietic progenitor cells.

177 cells, eliminating the numbers of malignant hematopoietic progenitor cells.

178 ell as a twofold expansion of CD34(+)CD45(+) hematopoietic progenitor cells.

179 corrects the phenotype of in vitro cultured hematopoietic progenitor cells.

180 nhancers marked with H3K4 monomethylation in hematopoietic progenitor cells.

181 ochondria compared with nonmalignant CD34(+) hematopoietic progenitor cells.

182 kemia (AML) cells while not affecting normal hematopoietic progenitor cells.

183 Using hematopoietic progenitors cells as a model, we demonstra

184 eukemia (AML) represents a clonal disease of hematopoietic progenitors characterized by acquired hete

185 this study, we test the assumption that the hematopoietic progenitor/colony-forming cells of the emb

186 In the thymus, hematopoietic progenitors commit to the T cell lineage a

187 ECs generated substantially more CD34+CD45+ hematopoietic progenitors compared with cells cocultured

188 Analysis of the hematopoietic progenitor compartment revealed elevated n

189 find that deletion of Cebpa rendered murine hematopoietic progenitors completely resistant to MLL-EN

190 Pep(-/-) hematopoietic progenitors demonstrate increased IFNAR si

191 and KD of miR-486-5p in primary fetal liver hematopoietic progenitors demonstrated that miR-486-5p c

192 T-cell development from hematopoietic progenitors depends on multiple transcript

193 ity, Akt and Erk hyperactivation, and skewed hematopoietic progenitor distribution.

194 L cells, as CHD4 depletion in normal CD34(+) hematopoietic progenitors does not increase their suscep

195 nsgene or by homozygous knock-out of Phd2 in hematopoietic progenitors driven by a Vav1-Cre transgene

196 Hematopoietic progenitors emerging from the aorta have a

197 phil lineage-committed, IL-5Ralpha-positive, hematopoietic progenitor (eosinophil progenitor).

198 kg/day activated telomerase 2-4 fold both in hematopoietic progenitors ex vivo and in bone marrow and

199 wed the visualization and differentiation of hematopoietic progenitors ex vivo in real-time with time

200 the c-Kit receptor tyrosine kinase to elicit hematopoietic progenitor expansion but can be toxic when

201 tion factor Col as an intrinsic regulator of hematopoietic progenitor fate.

202 tified before differentiating the cells into hematopoietic progenitors for transplantation.

203 c vascular-endothelial cadherin(+) cells and hematopoietic progenitor formation.

204 Pgamma are not restricted to fibroblasts, as hematopoietic progenitors from Cebpg(-/-) bone marrow al

205 imeric mice (Cdk5(+/+C) or Cdk5(-/-C)) using hematopoietic progenitors from either embryonic day 16.5

206 Finally, hematopoietic progenitors from fetuses exposed transplac

207 reviously demonstrated that the induction of hematopoietic progenitors from fibroblasts progresses th

208 gulation of SLPI in CD34(+) bone marrow (BM) hematopoietic progenitors from healthy individuals resul

209 omide-induced reprogramming was conserved in hematopoietic progenitors from individuals with sickle c

210 supporting B lymphopoiesis in vitro, whereas hematopoietic progenitors from mutant mice exhibit norma

211 ha-dependent inhibitory effects on malignant hematopoietic progenitors from patients with chronic mye

212 Ns to exert suppressive effects in malignant hematopoietic progenitors from patients with polycythemi

213 On day 14 of gestation, hematopoietic progenitors from wild-type or AHR-deficien

214 in irradiated recipients, consistent with a hematopoietic progenitor functional defect.

215 ng hematopoietic cells and bone marrow-based hematopoietic progenitors, functional evidence of the ce

216 its progression but did not prevent loss of hematopoietic progenitor functions.

217 found Cdc73 promotes expression of an early hematopoietic progenitor gene program that prevents diff

218 Flt3Cre+ KrasG12D fetal liver hematopoietic progenitors give rise to a myeloid disease

219 reases proliferation of these most primitive hematopoietic progenitors, giving rise to higher levels

220 edullary zone which contain undifferentiated hematopoietic progenitors has many, closely spaced membr

221 nclear, and direct infection of intermediate hematopoietic progenitors has not been established as a

222 distant lineage (fibroblasts) into 'induced hematopoietic progenitors' (iHPs).

223 ufficiency underlies the clonal expansion of hematopoietic progenitors in a large fraction of human m

224 However, erythroid and lymphoid hematopoietic progenitors in BM from CVB3-infected mice

225 us to explore the effects of antibiotics on hematopoietic progenitors in detail using a murine model

226 Despite markedly reduced cellularity of hematopoietic progenitors in E18.5 bone marrow, the numb

227 st mature granulocytes, but not toward human hematopoietic progenitors in humanized immune reconstitu

228 irculation prevented CBLB502 from protecting hematopoietic progenitors in lethally irradiated mice, i

229 ated proliferation of adoptively transferred hematopoietic progenitors in the bone marrow of mice wit

230 without adversely affecting human clonogenic hematopoietic progenitors in vitro, or murine hematopoie

231 th AF10 are sufficient to immortalize murine hematopoietic progenitors in vitro.

232 BCAP was expressed in BM hematopoietic progenitors, including lineage(-)Sca-1(+)c

233 Diverse hematopoietic progenitors, including myeloid populations

234 treatment with TNF-alpha of lineage-negative hematopoietic progenitors increased NK and myeloid diffe

235 n murine models, forced expression of MN1 in hematopoietic progenitors induces an aggressive myeloid

236 oid leukemia, mutated cells transform normal hematopoietic progenitors into "leukemic like" cells thr

237 olute a mixture of ES cells, fibroblasts and hematopoietic progenitors into high-quality chromatin st

238 normal gene expression networks to reprogram hematopoietic progenitors into preleukemic stem cells, a

239 t with user-defined properties that recruits hematopoietic progenitors into the implant.

240 ed with BCR-ABL1-positive ALL, a multipotent hematopoietic progenitor is affected by the BCR-ABL1 fus

241 standing how CMV interacts with LC and their hematopoietic progenitors is thus essential to develop i

242 p1 constitutively co-immunoprecipitated with hematopoietic progenitor kinase 1 (HPK1) in neutrophil-l

243 this issue of Blood, Jakob et al report that hematopoietic progenitor kinase 1 (HPK1) participates du

244 itment of the inhibitory signaling molecules hematopoietic progenitor kinase 1 and SH2-containing ino

245 Galphai2 deficiency in hematopoietic progenitors led to a small thymus, a doubl

246 Samd14 increased hematopoietic progenitor levels/activity and promoted si

247 rogenitor cells expressing SMC, myeloid, and hematopoietic progenitor-like properties and that differ

248 one marrow, especially in B-cell lineage and hematopoietic progenitors; lineage tracing identified th

249 known to function as a positive regulator of hematopoietic progenitor maintenance in the lymph gland

250 Drosophila hematopoietic progenitor maintenance involves both near

251 at, in Drosophila, olfactory signals control hematopoietic progenitor maintenance, thus uncovering a

252 cuit that controls quiescence of MB-HSCs and hematopoietic progenitors marked by histidine decarboxyl

253 n the cell population positive for the early hematopoietic progenitor marker CD41.

254 GATA1 suppression in ES and iPS cell-derived hematopoietic progenitors may enhance megakaryocyte prod

255 in the transcriptional states of developing hematopoietic progenitors may generally shape the mutati

256 proliferation and blocked differentiation of hematopoietic progenitors mediated, in part, by altered

257 sed by HSCs, and at lower levels by c-kit(+) hematopoietic progenitors, megakaryocytes, and Leptin Re

258 In the CD34(+) hematopoietic progenitor model of latency, viruses lacki

259 lymphoid lineage precursors from multipotent hematopoietic progenitors (MPP) in bone marrow.

260 atopoietic stem cells (HSCs) and multipotent hematopoietic progenitors (MPPs) are routinely isolated

261 e between proliferation and growth arrest in hematopoietic progenitors, myeloid lineage specific dele

262 re significantly reduced on Ezh2 deletion in hematopoietic progenitors of Jak2V617F mice.

263 cellular target of AHR activation is a fetal hematopoietic progenitor or stem cell.

264 ssion is not regulated by RUNX1-ETO in mouse hematopoietic progenitors or leukemic cells.

265 In Drosophila, a population of hematopoietic progenitors, or prohemocytes, within the l

266 is SCF variant elicited biased activation of hematopoietic progenitors over mast cells in vitro and i

267 A population of cells displaying a hematopoietic progenitor phenotype (CD34(++) CD45(low))

268 consist of G-CSF-dependent shifts of marrow hematopoietic progenitor populations including expansion

269 e, we sequenced RNA from eight primary human hematopoietic progenitor populations representing the ma

270 d exerts differential effects on the various hematopoietic progenitor populations.

271 orm a niche required to maintain the pool of hematopoietic progenitors (prohemocytes).

272 lymphoid cell fate is orchestrated in early hematopoietic progenitors remains poorly understood.

273 nitial activation of the Gata1 gene in early hematopoietic progenitors remains to be elucidated.

274 Ai to 20-30% of normal levels in multipotent hematopoietic progenitors resulted in clonal dominance o

275 d, consistent with a deficiency of primitive hematopoietic progenitors, serum levels of the hematopoi

276 for occluding-junctions in regulating niche-hematopoietic progenitor signalling and link this mechan

277 tor ARID3a is expressed in a subset of human hematopoietic progenitor stem cells in both healthy indi

278 damaged zone and the cardiac persistence of hematopoietic progenitors/stem cells after MI.

279 Recently, ST2 expression was described on hematopoietic progenitor subsets, where its function rem

280 uced beta1- and beta2-integrin expression on hematopoietic progenitors suggests that increased spleni

281 Mast cells are derived from hematopoietic progenitors that are known to migrate to a

282 ays an important role in the niche to expand hematopoietic progenitors through the modulation of seve

283 We report intermediate hematopoietic progenitors to be a novel target of infect

284 Hypercholesterolemia acts in platelets and hematopoietic progenitors to exacerbate thrombosis and a

285 pectedly, Cdk6 R31C impairs the potential of hematopoietic progenitors to repopulate upon adoptive tr

286 are cytokines, which regulate commitment of hematopoietic progenitors to the different blood lineage

287 (EndoMT) and the recruitment of circulating hematopoietic progenitors to the heart have been reporte

288 in vivo by creating bone marrow chimera from hematopoietic progenitors transduced with an inducible s

289 gnaling does not alter gene expression until hematopoietic progenitors transition from fetal to adult

290 howed that CARM1 is required for survival of hematopoietic progenitors under conditions that promote

291 ts lineage choice in differentiating primary hematopoietic progenitors using image patches from brigh

292 Using hematopoietic progenitors, we defined a signaling-based

293 y, CD34+ cell number, and frequency of early hematopoietic progenitors were noted.

294 h-risk LCH arises from somatic mutation of a hematopoietic progenitor, whereas low-risk disease arise

295 ures, addition of Indian Hh ligand increased hematopoietic progenitors, whereas chemical inhibition o

296 ensing dependence through RagA and mTORC1 in hematopoietic progenitors, which dynamically drive matur

297 iated silencing of TMEM131L in human CD34(+) hematopoietic progenitors, which were then grafted in NO

298 Stimulation of hematopoietic progenitors with macrophage colony-stimula

299 a highly selective ligand for E-selectin on hematopoietic progenitors with unexpected important cont

300 chemical inhibition of Hh signaling reduced hematopoietic progenitors without affecting primitive st